Merck Backs Generic H.I.V. Prevention Pill to Expand Global Access

Millions at risk of HIV infection in Latin America may lack access to a potentially life-saving prevention medication.

A pharmaceutical giant has opened the door to affordable HIV prevention for millions in Africa and South Asia, offering generic versions of a breakthrough pill for as little as five dollars a year — a price that transforms possibility into something approaching promise. Yet the architecture of this generosity reveals its own limits: Latin America, caught between the thresholds of poverty and wealth, finds itself outside the agreement's reach. The story of this drug is, in miniature, the story of global health itself — a system where access is not a right but a negotiation, and where geography

Merck Backs Generic H.I.V. Prevention Pill to Expand Global Access

Cobertura Relacionada

Receba o Register no seu e-mail